2VER image
Deposition Date 2007-10-26
Release Date 2008-01-08
Last Version Date 2024-11-13
Entry Detail
PDB ID:
2VER
Keywords:
Title:
Structural model for the complex between the Dr adhesins and carcinoembryonic antigen (CEA)
Biological Source:
Source Organism:
ESCHERICHIA COLI (Taxon ID: 562)
HOMO SAPIENS (Taxon ID: 9606)
Host Organism:
Method Details:
Experimental Method:
Conformers Calculated:
200
Conformers Submitted:
1
Selection Criteria:
REPRESENTATIVE STRUCTURE
Macromolecular Entities
Structures with similar UniProt ID
Protein Blast
Polymer Type:polypeptide(L)
Molecule:AFIMBRIAL ADHESIN AFA-III
Gene (Uniprot):afaE3
Chain IDs:A
Chain Length:143
Number of Molecules:1
Biological Source:ESCHERICHIA COLI
Structures with similar UniProt ID
Protein Blast
Polymer Type:polypeptide(L)
Molecule:ARCINOEMBRYONIC ANTIGEN-RELATED CELL ADHESION MOLECULE 5
Gene (Uniprot):CEACAM5
Chain IDs:B (auth: N)
Chain Length:110
Number of Molecules:1
Biological Source:HOMO SAPIENS
Ligand Molecules
Primary Citation
Binding of Dr Adhesins of Escherichia Coli to Carcinoembryonic Antigen Triggers Receptor Dissociation.
Mol.Microbiol. 67 420 ? (2008)
PMID: 18086185 DOI: 10.1111/J.1365-2958.2007.06054.X

Abstact

Carcinoembryonic antigen (CEA)-related cell adhesion molecules (CEACAMs) are host receptors for the Dr family of adhesins of Escherichia coli. To define the mechanism for binding of Dr adhesins to CEACAM receptors, we carried out structural studies on the N-terminal domain of CEA and its complex with the Dr adhesin. The crystal structure of CEA reveals a dimer similar to other dimers formed by receptors with IgV-like domains. The structure of the CEA/Dr adhesin complex is proposed based on NMR spectroscopy and mutagenesis data in combination with biochemical characterization. The Dr adhesin/CEA interface overlaps appreciably with the region responsible for CEA dimerization. Binding kinetics, mutational analysis and spectroscopic examination of CEA dimers suggest that Dr adhesins can dissociate CEA dimers prior to the binding of monomeric forms. Our conclusions include a plausible mechanism for how E. coli, and perhaps other bacterial and viral pathogens, exploit CEACAMs. The present structure of the complex provides a powerful tool for the design of novel inhibitory strategies to treat E. coli infections.

Legend

Protein

Chemical

Disease

Primary Citation of related structures
Feedback Form
Name
Email
Institute
Feedback